Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.67B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 3 |
TE Connectivity
TEL
|
+$948M |
| 4 |
Tesla
TSLA
|
+$910M |
| 5 |
Boeing
BA
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Visa
V
|
+$1.5B |
| 4 |
Morgan Stanley
MS
|
+$1.27B |
| 5 |
Exelon
EXC
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Healthcare | 17.88% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
PTC Therapeutics
PTCT
$5.78B
| $216M | 0.04% |
4,787,123
-3,105,676
| -39% | -$133M |
|
352
BWX Technologies
BWXT
$15.4B
| $216M | 0.04% |
1,938,303
-1,031,699
| -35% | -$126M |
|
353
JB Hunt Transport Services
JBHT
$25.6B
| $216M | 0.04% |
1,263,391
+1,024,295
| +428% | +$183M |
|
354
Kymera Therapeutics
KYMR
$8.68B
| $214M | 0.04% |
5,307,326
+688,967
| +15% | +$31.1M |
|
355
LyondellBasell Industries
LYB
$19.1B
| $213M | 0.04% |
2,870,666
+757,612
| +36% | +$63.7M |
|
356
iShares Core MSCI EAFE ETF
IEFA
$194B
| $213M | 0.04% |
3,026,735
+778,779
| +35% | +$57.5M |
|
357
Ameris Bancorp
ABCB
$5.97B
| $212M | 0.04% |
3,393,197
-168,969
| -5% | -$11.1M |
|
358
Structure Therapeutics
GPCR
$3.59B
| $211M | 0.04% |
7,785,614
+15,843
| +0.2% | +$562K |
|
359
Kroger
KR
$34.7B
| $211M | 0.04% |
3,451,923
+722,135
| +26% | +$42.4M |
|
360
iShares Core S&P 500 ETF
IVV
$898B
| $210M | 0.04% |
356,329
-5,764
| -2% | -$3.41M |
|
361
Globus Medical
GMED
$10.9B
| $206M | 0.04% |
2,496,599
-81,891
| -3% | -$6.46M |
|
|
AKRO
362
DELISTED
Akero Therapeutics
AKRO
| $205M | 0.04% |
7,376,961
-519,671
| -7% | -$15.7M |
|
363
Apogee Therapeutics
APGE
$10.2B
| $205M | 0.04% |
4,517,363
-297,037
| -6% | -$15.1M |
|
364
StepStone Group
STEP
$4.1B
| $202M | 0.04% |
3,485,680
-2,013,672
| -37% | -$125M |
|
365
Alkermes
ALKS
$8.32B
| $202M | 0.04% |
7,012,483
-5,645,762
| -45% | -$162M |
|
|
WCC
366
WESCO International
WCC
$18.2B
| $201M | 0.04% |
+1,111,989
| New | +$210M |
|
367
Denali Therapeutics
DNLI
$3.88B
| $201M | 0.04% |
9,847,951
-879,499
| -8% | -$22.5M |
|
368
Steven Madden
SHOO
$3.59B
| $201M | 0.04% |
4,718,033
-31,603
| -0.7% | -$1.42M |
|
369
Macerich
MAC
$7.2B
| $200M | 0.04% |
10,051,286
+8,988,665
| +846% | +$176M |
|
370
Belden
BDC
$5.01B
| $200M | 0.04% |
1,777,902
-354,984
| -17% | -$42.4M |
|
371
Neurocrine Biosciences
NBIX
$16.4B
| $199M | 0.04% |
1,457,425
+739,199
| +103% | +$91.4M |
|
372
Viavi Solutions
VIAV
$9.6B
| $198M | 0.04% |
19,614,684
+5,815,648
| +42% | +$57.4M |
|
373
SL Green Realty
SLG
$3.9B
| $197M | 0.04% |
2,893,454
-19,595
| -0.7% | -$1.45M |
|
374
Fortune Brands Innovations
FBIN
$6.24B
| $196M | 0.04% |
2,870,673
+1,110,021
| +63% | +$88.9M |
|
375
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| $196M | 0.04% |
334,686
-112,896
| -25% | -$66.5M |
|
Similar funds
Wellington Management Group's Q4 2024 Portfolio in Review
As of Q4 2024, Wellington Management Group held 2,066 positions worth $546B, down 4.3% from $571B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $25.7B in Q4 2024, closing 139 positions and reducing 894 holdings. Its most notable exit was Lineage Inc, an estimated $266M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in TE Connectivity worth $910M.
- Wellington Management Group's largest Q4 2024 buy was TE Connectivity: 6,362,160 shares worth $910M.
- Wellington Management Group added most to Eli Lilly in Q4 2024, an estimated $1.67B increase.
- Wellington Management Group's biggest Q4 2024 reduction was General Dynamics, cutting an estimated $1.7B.
- Wellington Management Group fully exited Lineage Inc in Q4 2024, selling an estimated $266M.
- Wellington Management Group's ten largest holdings make up 25% of its $546B portfolio in Q4 2024.
- Wellington Management Group opened 161 new positions and closed 139 in Q4 2024.
- Wellington Management Group's portfolio value fell 4.3% quarter-over-quarter to $546B.
Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.